Literature DB >> 12399450

Activation of initiator caspases through a stable dimeric intermediate.

Min Chen1, Aaron Orozco, David M Spencer, Jin Wang.   

Abstract

Structural and biochemical studies have revealed that procaspases form dimers prior to proteolytic activation. How the two procaspases interact in the dimer is unclear. To study the mechanisms of dimer-dependent caspase activation we used a heterodimeric system so that two caspase molecules can be specifically brought together. Surprisingly, only one caspase partner in the dimer needs to be enzymatically active for caspase processing and activation to occur. Caspase activation is inefficient in the dimer in the absence of intramolecular processing, suggesting that caspase activation is initiated via intramolecular processing. Homodimerization of caspase-8 or caspase-9 leads to the formation of a stable dimeric complex. However, heterodimerization between caspase-8 and caspases-3, -9, or -10 failed to induce stable dimer formation or caspase activation. Our data suggest that the formation of a stable dimeric intermediate initiates caspase activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399450     DOI: 10.1074/jbc.M210356200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane.

Authors:  Z T Schug; F Gonzalvez; R H Houtkooper; F M Vaz; E Gottlieb
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

3.  Alternative Fas-mediated cell death pathway is dependent on the different cleavage patterns of procaspase-8.

Authors:  Yufeng Li; Lei Qi; Atsushi Iwao; Kentaro Kihira; Francis Dida; Zhenhu Song; Eiichi Azuma; Yoshihiro Komada
Journal:  Mol Cell Biochem       Date:  2009-06-12       Impact factor: 3.396

4.  Generating mouse models of degenerative diseases using Cre/lox-mediated in vivo mosaic cell ablation.

Authors:  Masato Fujioka; Hisashi Tokano; Keiko Shiina Fujioka; Hideyuki Okano; Albert S B Edge
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

5.  Intra- and interdimeric caspase-8 self-cleavage controls strength and timing of CD95-induced apoptosis.

Authors:  Stefan M Kallenberger; Joël Beaudouin; Juliane Claus; Carmen Fischer; Peter K Sorger; Stefan Legewie; Roland Eils
Journal:  Sci Signal       Date:  2014-03-11       Impact factor: 8.192

6.  Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells.

Authors:  Manabu Kurokawa; Takahiro Ito; Chih-Sheng Yang; Chen Zhao; Andrew N Macintyre; David A Rizzieri; Jeffrey C Rathmell; Michael W Deininger; Tannishtha Reya; Sally Kornbluth
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-16       Impact factor: 11.205

7.  Promotion of Caspase Activation by Caspase-9-mediated Feedback Amplification of Mitochondrial Damage.

Authors:  Alan D Guerrero; Ingo Schmitz; Min Chen; Jin Wang
Journal:  J Clin Cell Immunol       Date:  2012-08-09

8.  Interdimer processing mechanism of procaspase-8 activation.

Authors:  David W Chang; Zheng Xing; Vanessa L Capacio; Marcus E Peter; Xiaolu Yang
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

9.  Complexes of human papillomavirus type 16 E6 proteins form pseudo-death-inducing signaling complex structures during tumor necrosis factor-mediated apoptosis.

Authors:  Maria Filippova; Valery A Filippov; Mercy Kagoda; Theodore Garnett; Nadya Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

10.  Crystal structure of procaspase-1 zymogen domain reveals insight into inflammatory caspase autoactivation.

Authors:  J Michael Elliott; Lionel Rouge; Christian Wiesmann; Justin M Scheer
Journal:  J Biol Chem       Date:  2008-12-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.